October

Vol 19 No. 1 2005

RENAL OSTEODYSTROPHY

1. In Memoriam – A tribute to Professor Jack W. Coburn
Fernando Carrera
Rev Port Nefrol Hipert 2005; 19 (Suppl 1): 5
Download

2. Foreword: Why a new supplement on renal osteodystrophy?
Fernando Carrera
Rev Port Nefrol Hipert 2005; 19 (Suppl 1): 7
Download

3. Renal osteodystrophy with special emphasis on secondary hyperparathyroidism.
Ewa Lewin, Jinxing Huan, Klaus Olgaard
Rev Port Nefrol Hipert 2005; 19 (Suppl 1): 9-18
Download

4. Pathogenesis of secondary hyperparathyroidism and parathyroid hyperplasia.
Eduardo Slatopolsky, Alex J. Brown, Adriana Dusso
Rev Port Nefrol Hipert 2005; 19 (Suppl 1): 19-29
Download

5. The different effects of high phosphate levels in chronic kidney disease.
Antonio Canalejo, Yolanda Almadén, Mariano Rodríguez
Rev Port Nefrol Hipert 2005; 19 (Suppl 1): 31-40
Download

6. The impact of cardiovascular calcifications in chronic kidney disease: novel pathomechanistic insights.
Markus Ketteler, Ralf Westenfeld, Vincent Brandenburg
Rev Port Nefrol Hipert 2005; 19 (Suppl 1): 41-49
Download

7. Vascular calcification, cardiovascular risk and arterial stiffness in haemodialysis patients.
Teresa Adragão
Rev Port Nefrol Hipert 2005; 19 (Suppl 1): 51-56
Download

8. Serum markers of bone turnover in the diagnosis of renal osteodystrophy.
Aníbal Ferreira
Rev Port Nefrol Hipert 2005; 19 (4): 241-299
Download

9. Role of vitamin D metabolites in the regulation of PTH synthesis and secretion in chronic kidney disease.
Justin Silver, Iddo Z. Ben Dov
Rev Port Nefrol Hipert 2005; 19 (Suppl 1): 73-80
Download

10. Vitamin D analogs for the management of secondary hyperparathyroidism.
Kevin J. Martin, Esther A. González
Rev Port Nefrol Hipert 2005; 19 (Suppl 1): 81-86
Download

11. Paracalcitol therapy for secondary hyperparathyroidism.
Myles Wolf, Ravi Thadhani
Rev Port Nefrol Hipert 2005; 19 (Suppl 1): 87-96
Download

12. Why target the parathyroid calcium-sensing receptor for the treatment of secondary hyperparathyroidism?
Pablo Ureña Torres, Dominique Prié, Laurent Beck, Gérard Friedlander
Rev Port Nefrol Hipert 2005; 19 (Suppl 1): 97-108
Download

13. How are calcimimetics influencing our management of uraemic hyperparathyroidism?
Simon J. Steddon, John Cunningham
Rev Port Nefrol Hipert 2005; 19 (Suppl 1): 109-115
Download

14. Sevelamer Hydrochloride: A new Approach to Hyperphosphatemia and Beneficial Effects Beyond Phosphate Control
João M. Frazão, Patrícia Martins, Carla Santos-Araújo
Rev Port Nefrol Hipert 2005; 19 (Suppl 1): 117-124
Download

15. Lanthanum carbonate: a new potent non-calcaemic phosphate binder.
Fouad Albaaj, Alastair J. Hutchison
Rev Port Nefrol Hipert 2005; 19 (Suppl 1): 125-133
Download

PATROCINADORES (Com base no apoio dado às actividades da SPN nos últimos 5 anos)

PLATINUM
OURO
PRATA
BRONZE
MEDTRONIC
MEDINFAR
SHIRE
OCTAPHARMA
FRANCE
JABA RECORDATI
TEVA FARMA
BAYER
LÉLEMAN
ALIVE PORTUGAL
BINDING SITE
BRISTOL MYERS SQUIBB
TELEMEDICINA
MUNDIPHARMA
MERIT MEDICAL PORTUGAL
A.MENARINI
HOSPIRA PORTUGAL
ADMINSAÚDE
SPRINGER HEALTH CARE
ASSOC. ESCLEROSE TUBEROSA
CARDINAL HEALTH
SPECULUM
EBSCO INTERNACIONAL
PERMANYER PORTUGAL
PARCEIRO PARA A COMUNICAÇÃO